Mitchell P. Kopin 13D and 13G filings for DMK Pharmaceuticals Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-06 10:04 am Unchanged |
2023-12-31 | 13G | DMK Pharmaceuticals Corporation DMKPQ |
Mitchell P. Kopin | 650,000 6.000% |
0 (Unchanged) |
Filing |
| 2023-08-10 4:03 pm Purchase |
2023-08-01 | 13G | DMK Pharmaceuticals Corporation DMKPQ |
Mitchell P. Kopin | 650,000 7.600% |
650,000 (New Position) |
Filing |